Stat3 controls lysosomal-mediated cell death in vivo PA Kreuzaler, AD Staniszewska, W Li, N Omidvar, B Kedjouar, J Turkson, ... Nature cell biology 13 (3), 303-309, 2011 | 340 | 2011 |
Killing a cancer: what are the alternatives? P Kreuzaler, CJ Watson Nature Reviews Cancer 12 (6), 411-424, 2012 | 209 | 2012 |
Remodeling mechanisms of the mammary gland during involution CJ Watson, PA Kreuzaler International Journal of Developmental Biology 55 (7-8-9), 757-762, 2011 | 173 | 2011 |
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion P Kreuzaler, Y Panina, J Segal, M Yuneva Molecular metabolism 33, 83-101, 2020 | 122 | 2020 |
Cell proliferation within small intestinal crypts is the principal driving force for cell migration on villi A Parker, OJ Maclaren, AG Fletcher, D Muraro, PA Kreuzaler, HM Byrne, ... The FASEB Journal 31 (2), 636, 2017 | 93 | 2017 |
SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors A Guzman, M Zelman-Femiak, JH Boergermann, S Paschkowsky, ... Journal of Biological Chemistry 287 (47), 39492-39504, 2012 | 76 | 2012 |
The role of cathepsins in involution and breast cancer CJ Watson, PA Kreuzaler Journal of mammary gland biology and neoplasia 14, 171-179, 2009 | 38 | 2009 |
All Things to All People TD Littlewood, P Kreuzaler, GI Evan Cell 151 (1), 11-13, 2012 | 37 | 2012 |
Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds RD Hume, S Pensa, EJ Brown, PA Kreuzaler, J Hitchcock, A Husmann, ... Scientific reports 8 (1), 12658, 2018 | 31 | 2018 |
Perturbation of the gut microbiota by antibiotics results in accelerated breast tumour growth and metabolic dysregulation BM Kirkup, A McKee, KA Makin, J Paveley, S Caim, C Alcon-Giner, ... BioRxiv, 553602, 2019 | 27 | 2019 |
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling P Kreuzaler, MA Clarke, EJ Brown, CH Wilson, RM Kortlever, N Piterman, ... Proceedings of the National Academy of Sciences 116 (44), 22399-22408, 2019 | 18 | 2019 |
The PI3K regulatory subunits p55α and p50α regulate cell death in vivo S Pensa, K Neoh, HK Resemann, PA Kreuzaler, K Abell, NJ Clarke, ... Cell Death & Differentiation 21 (9), 1442-1450, 2014 | 12 | 2014 |
ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis M Hennequart, SE Pilley, CF Labuschagne, J Coomes, L Mervant, ... Cell Reports 42 (6), 2023 | 10 | 2023 |
Determination of the physiological and pathological roles of E2F3 in adult tissues I Gamper, DL Burkhart, MJ Bywater, D Garcia, CH Wilson, PA Kreuzaler, ... Scientific Reports 7 (1), 9932, 2017 | 9 | 2017 |
Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer P Kreuzaler, P Inglese, A Ghanate, E Gjelaj, V Wu, Y Panina, ... Nature Metabolism 5 (11), 1870-1886, 2023 | 8 | 2023 |
Analysis of the involuting mouse mammary gland: an in vivo model for cell death B Lloyd-Lewis, TJ Sargeant, PA Kreuzaler, HK Resemann, S Pensa, ... Mammary Gland Development: Methods and Protocols, 165-186, 2017 | 4 | 2017 |
Defining the Role of Lysosomal Cathepsins in Breast Cancer K Teo, P Kreuzaler, A Staniszewska, C Watson European Journal of Surgical Oncology 38 (5), 448, 2012 | 1 | 2012 |
Isotope-Selective Gas Sensing Using Photoacoustic Non-Dispersive Spectroscopy G Rodriguez Gutierrez, L Marouani, A Ortiz Perez, P Kreuzaler, S Palzer Proceedings 97 (1), 207, 2024 | | 2024 |
Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling N Piterman, P Kreuzaler, MA Clarke, EJ Brown, CH Wilson, RM Kortlever, ... University of Leicester, 2019 | | 2019 |
1 Obligatory tumour heterogeneity driven by Myc overexpression: mechanistic insights and therapeutic strategies P Kreuzaler, M Clarke, E Brown, C Wilson, J Fisher, G Evan ESMO Open 3, A1, 2018 | | 2018 |